13 December 2018 08:46 CET

Karo Intressenter AB extends the acceptance period for its offer to the shareholders in Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

Fore more information, click here.

Latest news

09 March 2023
EQT Life Sciences Co-leads $88 Million Series B Financing in QurAlis
03 March 2023
EQT Value-Add Infrastructure to acquire SK Shieldus, a leading South Korean integrated security operator
01 March 2023
EQT Active Core Infrastructure announces first investment to acquire Radius Global Infrastructure
21 February 2023
EQT strengthens its commitment to South Korea – opens new office in Seoul
17 February 2023
EQT Private Equity exceeds minimum acceptance threshold in takeover offer for va-Q-tec